abstract gray background

Beyond Numbers: The Value of In-Trial Interview Data for Regulatory and Health Technology Assessment (HTA) Decision-Making

Regulatory health authorities now recognize the significance and value of in-trial qualitative interviews in gaining greater insight into the patient experience. These interviews provide supplementary data that can greatly enhance clinical trial design, interpretation of findings and product value for payers while addressing the unmet needs of patients.

Key insights from this webinar include:

  • Advantages of utilizing in-trial interview data in drug development
  • Use of in-trial data by regulators and health technology assessment (HTA) bodies
  • Methodological guidance and current trends
  • Recommendations for evidence generation planning
  • Opportunities for reimbursement decision-makers
Access the webinar by completing the form.